Approved products have been subjected to extensive research, including clinical trials, while cleared devices are evaluated based on their similarity to existing products
GIP Glucose-Dependent Insulinotropic Polypeptide Incretin K (K-cell) (Duodenum) GLP-1 GLP-1 receptor GIP receptor 2 GLP-1 2 GLP-1 (Glucagon-like Peptide-1) GIP (Glucose-dependent Insulinotropic Polypeptide) Mounjaro (Tirzepatide) GLP-1 GIP Mounjaro (Tirzepatide) GLP-1 GIP Dual GIP/GLP-1 Receptor Agonist : : SURMOUNT-1 tirzepatide semaglutide SURMOUNT-5 tirzepatide semaglutide 47% (Rubino et al., 2026, NEJM) : 3 (Triple agonist : GLP-1, GIP, Glucagon) Retatrutide 3 FAQ GLP-1 GIP GLP-1/GIP
Research Use Only (RUO) Not for Human or Veterinary Use Not for ConsumptionBAC Water Bacteriostatic Water Benzyl Alcohol Diluent Documentation Availab
The "right model" is access with guardrails, qualified clinicians, licensed pharmacies, validated quality testing and "meaningful" patient follow-up, according to the expert
For convenience, PharmaEasy offers the following packages with comprehensive test panels for people starting or already using GLP-1 medications